These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Hormone replacement therapy and cardioprotection: what is good and what is bad for the cardiovascular system? Rosano GM, Vitale C, Fini M. Ann N Y Acad Sci; 2006 Dec; 1092():341-8. PubMed ID: 17308159 [Abstract] [Full Text] [Related]
4. HRT and the primary prevention of cardiovascular disease. Stevenson JC. Maturitas; 2007 May 20; 57(1):31-4. PubMed ID: 17383835 [Abstract] [Full Text] [Related]
5. Sex hormone replacement therapy and modulation of vascular function in cardiovascular disease. Koledova VV, Khalil RA. Expert Rev Cardiovasc Ther; 2007 Jul 20; 5(4):777-89. PubMed ID: 17605655 [Abstract] [Full Text] [Related]
6. [Hormone replacement therapy and cardiovascular risk in menopausal women]. Simon T, Jaillon P. Arch Mal Coeur Vaiss; 2001 Feb 20; 94(2):132-8. PubMed ID: 11265551 [Abstract] [Full Text] [Related]
8. Compliance to hormone replacement therapy. Rozenberg S, Vandromme J, Kroll M, Pastijn A, Liebens F. Int J Fertil Menopausal Stud; 1995 Feb 20; 40 Suppl 1():23-32. PubMed ID: 7581586 [Abstract] [Full Text] [Related]
9. Hormone replacement therapy (HRT) and ischaemic heart disease: getting to the heart of the matter. Chew S, Ng SC. Singapore Med J; 2002 Jan 20; 43(1):41-4. PubMed ID: 12008777 [Abstract] [Full Text] [Related]
10. Implications of recent clinical trials of postmenopausal hormone therapy for management of cardiovascular disease. Rossouw JE. Ann N Y Acad Sci; 2006 Nov 20; 1089():444-53. PubMed ID: 17261787 [Abstract] [Full Text] [Related]
11. [Reflections on compliance in menopause hormone replacement therapy]. Berthet J, Tabaste JL, Vendittelli F. Rev Fr Gynecol Obstet; 1995 Dec 20; 90(12):548-51. PubMed ID: 8677410 [Abstract] [Full Text] [Related]
12. Vascular consequences of menopause and hormone therapy: importance of timing of treatment and type of estrogen. Dubey RK, Imthurn B, Barton M, Jackson EK. Cardiovasc Res; 2005 May 01; 66(2):295-306. PubMed ID: 15820198 [Abstract] [Full Text] [Related]
13. [Hormone replacement therapy and cardiovascular prevention. Where are we now?]. Lerman J, Siseles N. Medicina (B Aires); 2008 May 01; 68(3):251-7. PubMed ID: 18689159 [Abstract] [Full Text] [Related]
14. [Historical perspective of hormone replacement therapy]. Chanson P. Rev Prat; 2005 Feb 28; 55(4):369-75. PubMed ID: 15828614 [Abstract] [Full Text] [Related]
16. Postmenopausal hormone replacement therapy and the prevention of cardiovascular disease: a review. Abramson BL. J Cardiovasc Risk; 2002 Dec 28; 9(6):309-14. PubMed ID: 12478199 [Abstract] [Full Text] [Related]
17. Primary prevention of coronary heart disease in women. Rees M, Stevenson J, British Menopause Society Council. Menopause Int; 2008 Mar 28; 14(1):40-5. PubMed ID: 18380961 [Abstract] [Full Text] [Related]
18. Why a consensus conference on hormone replacement therapy and the cardiovascular system? Benagiano G, Farris M. Maturitas; 2004 Apr 15; 47(4):245-53. PubMed ID: 15063475 [Abstract] [Full Text] [Related]
19. [Pharmacology of estrogens and progestogens and cardiovascular risk]. Boissel JP, Cornu C. Therapie; 1999 Apr 15; 54(3):387-92. PubMed ID: 10500456 [Abstract] [Full Text] [Related]
20. The dilemma of menopause and hormone replacement--a challenge for women and health-care providers: knowledge of menopause and hormone therapy in Spanish menopausal women. Castelo-Branco C, Peralta S, Ferrer J, Palacios S, Cornago S, Quereda F. Climacteric; 2006 Oct 15; 9(5):380-7. PubMed ID: 17000585 [Abstract] [Full Text] [Related] Page: [Next] [New Search]